{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:38:00Z","timestamp":1791909480902,"version":"4.3.4"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jad.2025.120882","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:13:44Z","timestamp":1765988024000},"page":"120882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy"],"prefix":"10.1016","volume":"397","author":[{"given":"Faheem Ahmed","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuruliarizki Shinta","family":"Pandupuspitasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewin","family":"Tencomnao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn","family":"Chuchawankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120882_bb0005","doi-asserted-by":"crossref","first-page":"1527783","DOI":"10.3389\/fpain.2025.1527783","article-title":"Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial","volume":"6","author":"Aday","year":"2025","journal-title":"Frontiers in Pain Research"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41386-021-01155-7","article-title":"Prefrontal cortex, amygdala, and threat processing: implications for PTSD","volume":"47","author":"Alexandra Kredlow","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.120882_bb0020","series-title":"Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity","author":"Allohverdi","year":"2024"},{"key":"10.1016\/j.jad.2025.120882_bb0025","first-page":"27","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0030","article-title":"The use of psychedelic agents in the treatment of alcohol and tobacco dependence: an integrative revie","volume":"19","author":"Ara\u00fajo Borges","year":"2023","journal-title":"SMAD Rev. Electron. Salud Ment. Alcohol Drogas"},{"key":"10.1016\/j.jad.2025.120882_bb0035","first-page":"7","article-title":"Psilocybin-assisted psychotherapy: treating depression and anxiety with mushrooms","author":"Beck","year":"2020","journal-title":"Physician Assist. Stud. Stud. Artic."},{"issue":"3","key":"10.1016\/j.jad.2025.120882_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09540261.2021.1919062","article-title":"Psilocybin and MDMA for the treatment of trauma-related psychopathology","volume":"33","author":"Bird","year":"2021","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S2215-0366(24)00203-7","article-title":"Applying the EU regulatory framework for the clinical use of psychedelics","volume":"12","author":"Butlen-Ducuing","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2025.120882_bb0055","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1177\/0269881110367445","article-title":"The administration of Psilocybin to healthy, hallucinogen experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability","volume":"25","author":"Carhart-Harris","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-007-0930-9","article-title":"Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans","volume":"195","author":"Carter","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2025.120882_bb0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/rapm-2020-101273","article-title":"Chronic pain and psychedelics: a review and proposed mechanism of action","volume":"45","author":"Castellanos","year":"2020","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.jad.2025.120882_bb0075","article-title":"Mechanisms of Psilocybin on the treatment of post-traumatic stress disorder","volume":"02698811241286771","author":"Choi","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","author":"Copa","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jox12010004","article-title":"Psilocybin for treating psychiatric disorders: a psychonaut legend or a promising therapeutic perspective?","volume":"12","author":"Coppola","year":"2022","journal-title":"J. Xenobiot."},{"key":"10.1016\/j.jad.2025.120882_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.9740\/mhc.2017.01.024","article-title":"Clinical potential of Psilocybin as a treatment for mental health conditions","volume":"7","author":"Daniel","year":"2017","journal-title":"Ment. Health Clin."},{"issue":"5","key":"10.1016\/j.jad.2025.120882_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40337-024-01005-z","article-title":"Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians","volume":"12","author":"Downey","year":"2024","journal-title":"J. Eat. Disord."},{"issue":"24","key":"10.1016\/j.jad.2025.120882_bb0105","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/CM9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jad.2025.120882_bb0110","series-title":"World History Through Case Studies: Historical Skills in Practice","author":"Eaton","year":"2025"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/neurolint14020035","article-title":"Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jad.2025.120882_bb0120","first-page":"3","article-title":"Psychedelic drug use in healthy individuals: a review of benefits, costs, and implications for drug policy","author":"Elsey","year":"2017","journal-title":"Drug Sci. Policy Law"},{"key":"10.1016\/j.jad.2025.120882_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113612","article-title":"Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of Psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response","volume":"154","author":"Erkizia-Santamar\u00eda","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jad.2025.120882_bb0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/acps.12904","article-title":"Effects of psilocybin therapy on personality structure","volume":"138","author":"Erritzoe","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.120882_bb0135","first-page":"1","article-title":"Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats","author":"Floris","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0140","series-title":"Enlightenment and the Psychology of Self-transcendence: Pathways to Fundamental Well-being and Prosocial Behavior","author":"Furnell","year":"2025"},{"key":"10.1016\/j.jad.2025.120882_bb0145","doi-asserted-by":"crossref","first-page":"100240","DOI":"10.1016\/j.jadr.2021.100240","article-title":"Evaluating the risk of psilocybin for the treatment of bipolar depression: a review of the research literature and published case studies","volume":"6","author":"Gard","year":"2021","journal-title":"Journal of Affective Disorders Reports"},{"issue":"3","key":"10.1016\/j.jad.2025.120882_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default mode network modulation by psychedelics: a systematic review","volume":"26","author":"Gattuso","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1176\/appi.ajp.20230914","article-title":"Primum non nocere: the onus to characterize the potential harms of psychedelic treatment","volume":"182","author":"Ghaznavi","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0126660822258502231120074036","article-title":"Pharmacotherapy of psychological disorders using psychedelic drugs: a treatise for psychiatrists","volume":"21","author":"Ghosh","year":"2025","journal-title":"Curr. Psychiatry Res. Rev."},{"issue":"12","key":"10.1016\/j.jad.2025.120882_bb0165","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2020.1826931","article-title":"The emerging role of psilocybin and MDMA in the treatment of mental illness","volume":"20","author":"Gill","year":"2020","journal-title":"Expert Rev. Neurother."},{"issue":"11","key":"10.1016\/j.jad.2025.120882_bb0170","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/acsptsci.2c00177","article-title":"Structure\u2013activity relationships for psilocybin, baeocystin, aeruginascin, and related analogues to produce pharmacological effects in mice","volume":"5","author":"Glatfelter","year":"2022","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.jad.2025.120882_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of Psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120882_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120882_bb0185","series-title":"Tripping Over Trauma: A Proposal of Psilocybin-assisted Therapy for Comorbid Post-traumatic Stress Disorder and Depression","author":"Gomez","year":"2022"},{"issue":"18","key":"10.1016\/j.jad.2025.120882_bb0190","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jad.2025.120882_bb0195","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41386-023-01648-7","article-title":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","volume":"48","author":"Goodwin","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jad.2025.120882_bb0200","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berlin)"},{"issue":"12","key":"10.1016\/j.jad.2025.120882_bb0205","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0215","series-title":"Psychological Aspects of Cancer: A Guide to Emotional and Psychological Consequences of Cancer, Their Causes, and Their Management","first-page":"69","article-title":"Use of the classic hallucinogen psilocybin for treatment of existential distress associated with cancer","author":"Grob","year":"2022"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jad.2025.120882_bb0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/02698811231179910","article-title":"Attenuation of psilocybin mushroom effects during and after SSRI\/SNRI antidepressant use","volume":"37","author":"Gukasyan","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0230","article-title":"The Yale manual for psilocybin-assisted therapy of depression (using acceptance and commitment therapy as a therapeutic frame)","author":"Guss","year":"2020","journal-title":"PsyArXiv"},{"key":"10.1016\/j.jad.2025.120882_bb0235","article-title":"A systematic review of participant diversity in psychedelic-assisted psychotherapy trials","volume":"116359","author":"Haft","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120882_bb0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.25166\/IJSRM\/2022.20.3.2","article-title":"The role of psychedelics in managing anxiety, depression, and flashbacks of individuals with post-traumatic stress disorder","author":"Hammel","year":"2022","journal-title":"Int. J. Sci. Res. Methodol."},{"issue":"9","key":"10.1016\/j.jad.2025.120882_bb0245","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1038\/s41380-023-02291-w","article-title":"Functional connectivity of amygdala subnuclei in PTSD: a narrative review","volume":"28","author":"Haris","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.120882_bb0250","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/13634615221100385","article-title":"Modalities of the psychedelic experience: microclimates of set and setting in hallucinogen research and culture","volume":"59","author":"Hartogsohn","year":"2022","journal-title":"Transcult. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of Psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jad.2025.120882_bb0260","first-page":"27","article-title":"Psilocybin-assisted group therapy: a new hope for demoralization","author":"Hendricks","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jad.2025.120882_bb0265","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0269881117735685","article-title":"The relationships of classic psychedelic use with criminal behavior in the United States adult population","volume":"32","author":"Hendricks","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0275","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hlca.19590420518","article-title":"Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen","volume":"42","author":"Hofmann","year":"1959","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.jad.2025.120882_bb0280","series-title":"On Serotonin, Psychedelics, Entactogens and Psychoplastogens in Depression, Anxiety, Post-traumatic Stress, and Related Disorders","author":"Hoyer","year":"2024"},{"key":"10.1016\/j.jad.2025.120882_bb0285","series-title":"Neurogenesis, Neurodegenerative Diseases and Treatment Using Psilocybin","author":"Hughes","year":"2023"},{"key":"10.1016\/j.jad.2025.120882_bb0290","series-title":"Uppers, Downers, All Arounders: Physical and Mental Effects of Psychoactive Drugs","author":"Inaba","year":"2014"},{"key":"10.1016\/j.jad.2025.120882_bb0295","first-page":"35","article-title":"Psilocybin occasioned mystical-type experiences","author":"James","year":"2020","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"11","key":"10.1016\/j.jad.2025.120882_bb0300","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/rapm-2024-105532","article-title":"Psilocybin and chronic neuropathic pain: a systematic review","volume":"50","author":"Jevotovsky","year":"2025","journal-title":"Regional Anesthesia & Pain Medicine"},{"key":"10.1016\/j.jad.2025.120882_bb0305","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/7854_2022_327","article-title":"Classic psychedelics in addiction treatment: the case for Psilocybin in tobacco smoking cessation","author":"Johnson","year":"2022","journal-title":"Disruptive Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0310","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/0269881116675781","article-title":"The role of psychedelics in palliative care reconsidered: a case for Psilocybin","volume":"30","author":"Kelmendi","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/7854_2022_366","article-title":"Psilocybin for trauma-related disorders","author":"Khan","year":"2022","journal-title":"Disruptive Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jigims.jigims_60_23","article-title":"Psilocybin for the treatment of post-traumatic stress disorder: a magic to treat a harmony of illusions?","volume":"10","author":"Khanna","year":"2024","journal-title":"J. Indira Gandhi Inst. Med. Sci."},{"issue":"4","key":"10.1016\/j.jad.2025.120882_bb0325","doi-asserted-by":"crossref","first-page":"320","DOI":"10.37506\/ijfmt.v16i4.18608","article-title":"Fungal hallucinogens: chemistry, synthesis, behavior, toxicity and detection methods in forensic perspective","volume":"16","author":"Kirubakarababu","year":"2022","journal-title":"Indian J. Forensic Med. Toxicol."},{"issue":"8","key":"10.1016\/j.jad.2025.120882_bb0330","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0340","series-title":"The Effect of Psilocybin on Personality","author":"LaBua","year":"2021"},{"key":"10.1016\/j.jad.2025.120882_bb0345","first-page":"29","article-title":"The effects of consciousness-expanding drugs on prisoner rehabilitation","volume":"10","author":"Leary","year":"1969","journal-title":"Psychedelic Rev."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0350","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s10020-024-01013-4","article-title":"Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review","volume":"30","author":"Lima da Cruz","year":"2024","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.jad.2025.120882_bb0355","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/molecules26102948","article-title":"The therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0360","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/02791072.2020.1849879","article-title":"Long-term amelioration of OCD symptoms in a patient with chronic consumption of psilocybin-containing mushrooms","volume":"53","author":"Lugo-Radillo","year":"2021","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jad.2025.120882_bb0365","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/0269881117748902","article-title":"Increased nature relatedness and decreased authoritarian political views after Psilocybin for treatment-resistant depression","volume":"32","author":"Lyons","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0375","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WNF.0000000000000617","article-title":"Exploring psychedelics pharmacology: a scoping review charting the course of psilocybin pharmacokinetics","volume":"48","author":"Manzano-Nunez","year":"2025","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14737175.2024.2445016","article-title":"Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective","volume":"25","author":"Marazziti","year":"2025","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2025.120882_bb0385","series-title":"Use Cases for Art Therapy Intervention in Clinical Psychedelic Praxis","author":"Maud","year":"2025"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0390","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of Psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after Psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1176\/appi.ajp.20230787","article-title":"Psychedelic regulation beyond the Controlled Substances Act: a three-dimensional framework for characterizing policy options","volume":"182","author":"Mian","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0400","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jclp.20000","article-title":"The phenomenon of quantum change","volume":"60","author":"Miller","year":"2004","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.jad.2025.120882_bb0405","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of Psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0410","series-title":"Chemical Composition and In Vitro Bioaccessibility of Bioactive Compounds From Different Sporocarp Parts of a Medicinal Mushroom","author":"Murrube","year":"2025"},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0415","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15265161.2024.2433428","article-title":"Supportive touch in psychedelic assisted therapy","volume":"25","author":"Neitzke-Spruill","year":"2025","journal-title":"Am. J. Bioeth."},{"issue":"4","key":"10.1016\/j.jad.2025.120882_bb0420","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/psymed.2023.0012","article-title":"Psilocybin for opioid use disorder in two adults stabilized on buprenorphine: a technical report on study modifications and preliminary findings","volume":"1","author":"Nicholas","year":"2023","journal-title":"Psychedelic Med."},{"key":"10.1016\/j.jad.2025.120882_bb0425","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41429-020-0311-8","article-title":"Psilocybin: from ancient magic to modern medicine","volume":"73","author":"Nichols","year":"2020","journal-title":"J. Antibiot."},{"key":"10.1016\/j.jad.2025.120882_bb0430","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/plants9091127","article-title":"Phytochemical, cytotoxicity, antioxidant and anti-inflammatory effects of Psilocybe natalensis magic mushroom","volume":"9","author":"Nkadimeng","year":"2020","journal-title":"Plants"},{"issue":"3","key":"10.1016\/j.jad.2025.120882_bb0435","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1353\/ppp.2021.0032","article-title":"Containment matters: set and setting in contemporary psychedelic psychiatry","volume":"28","author":"Noorani","year":"2021","journal-title":"Philos. Psychiatry Psychol."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0440","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/s41598-024-52967-8","article-title":"Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study","volume":"14","author":"Pagni","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.120882_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120096","article-title":"Psilocybin-assisted psychotherapy for depression: emerging research on a psychedelic compound with a rich history","volume":"434","author":"Pearson","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jad.2025.120882_bb0450","series-title":"Microdosing as a Response to the Meaning Crisis","author":"Petranker","year":"2020"},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0455","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0269881120953994","article-title":"Microdosing psychedelics: subjective benefits and challenges, substance testing behavior, and the relevance of intention","volume":"36","author":"Petranker","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0460","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of Psilocybin on empathy and moral decision-making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.jad.2025.120882_bb0465","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of psilocybin on empathy and moral decision-making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0470","article-title":"Psilocybin for Depression and Anxiety in Cancer Patients","volume":"239","author":"Quest","year":"2025"},{"issue":"2","key":"10.1016\/j.jad.2025.120882_bb0475","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/ijms22020835","article-title":"A single dose of Psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0480","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41398-023-02690-1","article-title":"Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats","volume":"13","author":"Reinwald","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.120882_bb0485","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109174","article-title":"Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care","volume":"216","author":"Ross","year":"2022","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.jad.2025.120882_bb0495","first-page":"490","article-title":"Altered states and social bonds: effects of MDMA and serotonergic psychedelics on social behavior as a mechanism underlying substance-assisted therapy","volume":"9","author":"Schmid","year":"2024","journal-title":"Biol. Psychiatry: Cognit. Neurosci. Neuroimaging"},{"key":"10.1016\/j.jad.2025.120882_bb0500","series-title":"Delicioso: A History of Food in Spain","author":"Sevilla","year":"2025"},{"key":"10.1016\/j.jad.2025.120882_bb0505","article-title":"Drug Policy","volume":"130","author":"Shannon","year":"2025"},{"key":"10.1016\/j.jad.2025.120882_bb0510","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1177\/0269881116675764","article-title":"Psilocybin and palliative end-of-life care","volume":"30","author":"Shelton","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0515","series-title":"Knowledge Synthesis in the Science of Psilocybin: Scoping Reviews of Clinical and Preclinical Research","author":"Shore","year":"2023"},{"key":"10.1016\/j.jad.2025.120882_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50612-3","article-title":"Characterization and prediction of acute and sustained response to psychedelic Psilocybin in a mindfulness group retreat","volume":"9","author":"Smigielski","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.120882_bb0525","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.jad.2025.120882_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.948729","article-title":"Lasting increases in trait mindfulness after Psilocybin correlate positively with the mystical-type experience in healthy individuals","volume":"13","author":"S\u00f8ndergaard","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.120882_bb0535","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0269881116675783","article-title":"Psilocybin-assisted psychotherapy for dying cancer patients\u2014aiding the final trip","volume":"30","author":"Spiegel","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2025.120882_bb0540","doi-asserted-by":"crossref","first-page":"e00688","DOI":"10.1002\/prp2.688","article-title":"Psychedelic\u2010assisted therapy for functional neurological disorders: a theoretical framework and review of prior reports","volume":"8","author":"Stewart","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0545","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2024.01.002","article-title":"Neural mechanisms of resting-state networks and the amygdala underlying the cognitive and emotional effects of psilocybin","volume":"96","author":"Stoliker","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0550","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-024-01353-0","article-title":"Pain and perception: exploring psychedelics as novel therapeutic agents in chronic pain management","volume":"29","author":"Strand","year":"2025","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.jad.2025.120882_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.104060","article-title":"Safety pharmacology of acute psilocybin administration in healthy participants","volume":"3","author":"Straumann","year":"2024","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.jad.2025.120882_bb0560","first-page":"1","article-title":"Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases","author":"Szpr\u0119giel","year":"2024","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0565","first-page":"1","article-title":"High hopes: legal and ethical issues with post-trial access to psychedelic drugs","volume":"28","author":"Terris","year":"2025","journal-title":"J. Health Care Law Policy"},{"key":"10.1016\/j.jad.2025.120882_bb0570","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0269881118771782","article-title":"Psychedelic use and intimate partner violence: the role of emotion regulation","volume":"32","author":"Thiessen","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0575","series-title":"Exposure Therapy Under Psilocybin for General Anxiety Disorder and Claustrophobia","author":"Thorens","year":"2023"},{"key":"10.1016\/j.jad.2025.120882_bb0580","doi-asserted-by":"crossref","first-page":"1134454","DOI":"10.3389\/fpsyt.2023.1134454","article-title":"Therapeutic effect of psilocybin in addiction: a systematic review","volume":"14","author":"van der Meer","year":"2023","journal-title":"Front. Psych."},{"issue":"9","key":"10.1016\/j.jad.2025.120882_bb0585","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/biomedicines8090331","article-title":"Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases\u2014a systematic review and meta-analysis of clinical trials","volume":"8","author":"Vargas","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jad.2025.120882_bb0590","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.jad.2025.120882_bb0595","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.jad.2025.120882_bb0600","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/0269881116642538","article-title":"Hallucinogen use and intimate partner violence: prospective evidence consistent with protective effects among men with histories of problematic substance use","volume":"30","author":"Walsh","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0605","series-title":"Medical Research Ethics: Challenges in the 21st Century","first-page":"235","article-title":"Opening death\u2019s door: psilocybin and existential suffering in palliative care","author":"Waring","year":"2023"},{"key":"10.1016\/j.jad.2025.120882_bb0610","first-page":"325","article-title":"Division of mycology: the hallucinogenic mushrooms of Mexico: an adventure in ethnomycological exploration*","volume":"21","author":"Wasson","year":"1959","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.jad.2025.120882_bb0615","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1111\/bcp.16045","article-title":"From taboo to treatment: the emergence of psychedelics in the management of pain and opioid use disorder","volume":"90","author":"Weleff","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.120882_bb0620","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/pmt-2017-0068","article-title":"Lysergic acid diethylamide and Psilocybin for the management of patients with persistent pain: a potential role?","volume":"8","author":"Whelan","year":"2018","journal-title":"Pain Manag."},{"issue":"1","key":"10.1016\/j.jad.2025.120882_bb0625","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/ijms25010241","article-title":"Molecular and medical aspects of psychedelics","volume":"25","author":"Wojtas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.jad.2025.120882_bb0630","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/ijms23126713","article-title":"Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jad.2025.120882_bb0635","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s43440-023-00539-4","article-title":"Cardiovascular safety of psychedelic medicine: current status and future directions","volume":"75","author":"Ws\u00f3\u0142","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jad.2025.120882_bb0640","author":"Yale University"},{"key":"10.1016\/j.jad.2025.120882_bb0645","author":"Yale University"},{"issue":"4","key":"10.1016\/j.jad.2025.120882_bb0650","doi-asserted-by":"crossref","first-page":"e245960","DOI":"10.1001\/jamanetworkopen.2024.5960","article-title":"Acute adverse effects of therapeutic doses of psilocybin: a systematic review and meta-analysis","volume":"7","author":"Yerubandi","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2025.120882_bb0655","first-page":"14","article-title":"A phenomenological examination of psilocybin and its positive and persisting aftereffects","author":"Zamaria","year":"2016","journal-title":"NeuroQuantology"},{"key":"10.1016\/j.jad.2025.120882_bb0660","first-page":"11","article-title":"Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation","author":"Zeifman","year":"2020","journal-title":"Front. Psych."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725023249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725023249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:44:14Z","timestamp":1768941854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725023249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":132,"alternative-id":["S0165032725023249"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120882","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120882"}}